It is a pharma public limited company based in C, Rajasthan, India, established in 1998.
1998 | C, Rajasthan, India | ActiveScortis Pharma Limited, a active public limited company, was established on 23 March 1998 in C, Rajasthan, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232RJ1998PLC014717. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Aniruddh Modi (Director), Anjali Modi (Director), Ashish Modi (Director). Past directors included Vishwambhar Modi, Daya Nandan Modi, Gautam Nathany. It holds no open charges and ₹3.20 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 48, Shivaji Nagar,Civil Lines,Jaipur. Jaipur., C, Rajasthan.
U24232RJ1998PLC014717
014717
23 March 1998
₹1.50 M
₹1.50 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Scortis Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aniruddh Modi | Director | 06 Jul 2019 | Current |
| Anjali Modi | Director | 30 May 2000 | Current |
| Ashish Modi | Director | 30 Mar 1998 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Jul 2019 | Past |
| Pramod Abcsdd | Director | 06 Jul 2019 | Past |
| Pramod Abcsdd | Director | 21 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Scortis Pharma Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 3.25% decrease. The company also saw a substantial improvement in profitability, with a 167.5% increase in profit. The company's net worth Soared by an impressive increase of 22.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Scortis Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹3,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Feb 2016 | Kotak Mahindra Prime Limited | ₹1.70 M | Satisfied |
| 23 May 2005 | Bank Of Baroda | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Scortis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Scortis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scortis Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Scortis Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge registered on 12 Feb 2016 via Charge ID 10623736 with Kotak Mahindra Prime Limited was fully satisfied on 09 Sep 2024. was recorded as a recent event.
A charge registered on 23 May 2005 via Charge ID 90071496 with Bank Of Baroda was fully satisfied on 23 Aug 2024. was recorded as a recent event.
The activity Scortis Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was completed.
The activity Aniruddh Modi was appointed as a Director was appointed as a Director on 06 Jul 2019 & has been associated with this company since 6 years 4 months . was completed.
A charge with Kotak Mahindra Prime Limited amounted to Rs. 1.70 M with Charge ID 10623736 was registered on 12 Feb 2016. was recorded as a recent event.
The CIN of Scortis Pharma Limited is U24232RJ1998PLC014717.
Scortis Pharma Limited is headquartered at 48, Shivaji Nagar,Civil Lines,Jaipur. Jaipur., C, Rajasthan.
Scortis Pharma Limited was incorporated on 23 March 1998.
The current directors of Scortis Pharma Limited are
The primary industry of Scortis Pharma Limited is Manufacturing.
Scortis Pharma Limited is unlisted.
The authorized capital of Scortis Pharma Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Scortis Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX